H+H International A/S (CPH: HH)
Denmark
· Delayed Price · Currency is DKK
79.20
+1.10 (1.41%)
Nov 22, 2024, 2:26 PM CET
H+H International Revenue
H+H International had revenue of 729.00M DKK in the quarter ending September 30, 2024, with 4.29% growth. This brings the company's revenue in the last twelve months to 2.70B, down -6.32% year-over-year. In the year 2023, H+H International had annual revenue of 2.67B, down -25.86%.
Revenue (ttm)
2.70B
Revenue Growth
-6.32%
P/S Ratio
0.46
Revenue / Employee
2.25M
Employees
1,261
Market Cap
1.28B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.67B | -932.00M | -25.86% |
Dec 31, 2022 | 3.60B | 584.00M | 19.34% |
Dec 31, 2021 | 3.02B | 366.00M | 13.79% |
Dec 31, 2020 | 2.65B | -186.00M | -6.55% |
Dec 31, 2019 | 2.84B | 317.00M | 12.56% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novozymes A/S | 22.71B |
SP Group A/S | 2.85B |
Flügger group A/S | 2.21B |
Scandinavian Investment Group A/S | 28.00M |
RIAS A/S | 307.11M |
Hove A/S | 176.31M |
Novo Nordisk A/S | 270.58B |
DSV A/S | 160.12B |